DAB2IP and breast cancer: The epithelial cell adhesion molecule EPCAM — a transmembrane glycoprotein overexpressed particularly in tumor-initiating cells (TICs) in various cancers, including breast cancer — was also more highly expressed in DAB2IP-low Luminal A tumors (22).